Dipexium Pharmaceut (DPRX) Misses Q3 EPS by 2c

Dipexium Pharmaceut (NASDAQ: DPRX) reported Q3 EPS of ($0.49), $0.02 worse than the analyst estimate of ($0.47).

For earnings history and earnings-related data on Dipexium Pharmaceut (DPRX) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• Morgan Stanley course-corrects their semiconductor equipment outlook on demand